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Background:  ESC guidelines for the management of NSTE-ACS recommend an early invasive strategy in high-risk patients. In clinical practice, only 
a minority of patients are referred to an invasive strategy.
Methods:  Between October 2006 to October 2008, 21,582 consecutive patients with ACS were enrolled into the Euro-Heart-Survey ACS-Registry to 
document treatment and hospital complications. We examined the development of early invasive treatment in patients with NSTE-ACS over the time 
of 2 years by dividing the population into 4 periods of 6 months, according to date of admission.
Results:  During the study period, a total of 11,550 patients with NSTE-ACS were enrolled. Over the time period of 2 years the prevalence of 
prior PCI and diabetes increased whereas prior MI as well as prior stroke and renal failure decreased. No differences were found in age, gender 
and clinical presentation with cardiogenic shock. From 2006 to 2008 the number of patients with NSTE-ACS undergoing coronary angiography 
significantly increased from initially 55.7% to finally 64.5%. At the same time more patients did undergo PCI in the acute setting of NSTE-ACS. No 
differences were found in clinical outcome (death / MI / stroke) between the 4 time periods of 6 months each. 
Period 1 Period 2 Period 3 Period 4 p-value for trend
Age (years) 68.7 67.0 69.1 68.5 ns
Female Gender 36.5% 37.6% 37.0% 35.1% ns
Prior MI 32.4% 27.7% 30.5% 28.1% <0.01
Prior PCI 17.0% 16.1% 20.9% 19.9% <0.01
Prior CABG 6.4% 5.7% 7.9% 7.0% ns
Prior Stroke 7.8% 5.2% 6.0% 5.2% <0.01
Renal Failure 11.6% 9.0% 10.3% 8.3% <0.01
Diabetes 29.2% 29.9% 32.3% 31.2% <0.05
Killip 4 1.2% 1.2% 1.3% 1.0% ns
NSTEMI 58.3% 52.0% 54.8% 55.1% ns
Treatment Approach
Primary conservative 44.0% 40.0% 34.4% 35.2% <0.01
Coronary Angio, then conservative 13.4% 14.8% 15.2% 12.3% ns
Coronary Angio, then PCI 39.6% 41.7% 47.0% 48.8% <0.01
Coronary Angio, then CABG 3.0% 3.5% 3.4% 3.6% ns
Acute medical treatment
Aspirin 94.7% 92.8% 92.4% 93.7% ns
Clopidogrel 63.9% 81.2% 85.4% 90.9% <0.01
GP IIb/IIIa 15.4% 12.2% 12.0% 8.8% <0.01
Hospital Outcome
Death 2.8% 2.6% 3.0% 2.6% ns
MI 1.6% 1.2% 1.3% 1.2% ns
Stroke 0.7% 0.4% 0.4% 0.4% ns
Conclusion: Between 2006 and 2008 the number of NSTE-ACS patients undergoing coronary angiography and PCI significantly increased in clinical 
practice in Europe. No differences were found in in-hospital clinical endpoints between the 4 time periods of 6 months.
